235 related articles for article (PubMed ID: 14592917)
1. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Ann N Y Acad Sci; 2003 Sep; 998():481-90. PubMed ID: 14592917
[TBL] [Abstract][Full Text] [Related]
2. Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies.
Romi F; Gilhus NE; Varhaug JE; Myking A; Aarli JA
Eur Neurol; 2003; 49(4):210-7. PubMed ID: 12736536
[TBL] [Abstract][Full Text] [Related]
3. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Eur J Neurol; 2002 Jan; 9(1):55-61. PubMed ID: 11784377
[TBL] [Abstract][Full Text] [Related]
4. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
[No Abstract] [Full Text] [Related]
5. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
Romi F; Skeie GO; Aarli JA; Gilhus NE
Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
Skeie GO; Romi F
Eur J Neurol; 2008 Oct; 15(10):1029-33. PubMed ID: 18717725
[TBL] [Abstract][Full Text] [Related]
7. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.
Romi F; Gilhus NE; Varhaug JE; Myking A; Aarli JA
Eur J Neurol; 2003 Nov; 10(6):701-6. PubMed ID: 14641516
[TBL] [Abstract][Full Text] [Related]
8. Muscle autoantibodies in subgroups of myasthenia gravis patients.
Romi F; Skeie GO; Aarli JA; Gilhus NE
J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
[TBL] [Abstract][Full Text] [Related]
9. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
Shelton GD; Skeie GO; Kass PH; Aarli JA
Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
[TBL] [Abstract][Full Text] [Related]
10. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
Chen XJ; Qiao J; Xiao BG; Lu CZ
J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
[TBL] [Abstract][Full Text] [Related]
11. [Thymectomy and muscle antibodies in myasthenia gravis].
Romi F; Gilhus NE; Aarli JA
Tidsskr Nor Laegeforen; 2004 Mar; 124(5):629-31. PubMed ID: 15004605
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis in individuals over 40.
Aarli JA; Romi F; Skeie GO; Gilhus NE
Ann N Y Acad Sci; 2003 Sep; 998():424-31. PubMed ID: 14592910
[TBL] [Abstract][Full Text] [Related]
13. Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy.
Wolfe GI; Kaminski HJ; Jaretzki A; Swan A; Newsom-Davis J
Ann N Y Acad Sci; 2003 Sep; 998():473-80. PubMed ID: 14592916
[TBL] [Abstract][Full Text] [Related]
14. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients.
Yamamoto AM; Gajdos P; Eymard B; Tranchant C; Warter JM; Gomez L; Bourquin C; Bach JF; Garchon HJ
Arch Neurol; 2001 Jun; 58(6):885-90. PubMed ID: 11405802
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.
Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
Muscle Nerve; 1998 Mar; 21(3):329-35. PubMed ID: 9486861
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes.
Skeie GO; Pandey JP; Aarli JA; Gilhus NE
Autoimmunity; 1997; 26(2):111-6. PubMed ID: 9546812
[TBL] [Abstract][Full Text] [Related]
17. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.
Takamori M; Motomura M; Kawaguchi N; Nemoto Y; Hattori T; Yoshikawa H; Otsuka K
Neurology; 2004 May; 62(10):1894-6. PubMed ID: 15159506
[TBL] [Abstract][Full Text] [Related]
18. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
[TBL] [Abstract][Full Text] [Related]
20. Titin and ryanodine receptor antibodies in myasthenia gravis.
Skeie GO; Aarli JA; Gilhus NE
Acta Neurol Scand Suppl; 2006; 183():19-23. PubMed ID: 16637922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
